New drug could unmask hidden cancer cells
NCT ID NCT07392970
Summary
This is a small, early-stage study to see if a single injection of a drug called motixafortide can help doctors find very small amounts of leftover leukemia cells in the blood. The study involves adults with acute myeloid leukemia (AML) who are in remission after initial chemotherapy. The main goal is to learn if the drug makes these hidden cancer cells easier to detect in a standard blood test, which could help guide future treatment decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.